Edesa Biotech (EDSA) Tops Q1 EPS by 67c

Edesa Biotech (NASDAQ: EDSA) reported Q1 EPS of ($0.54), $0.67 better than the analyst estimate of ($1.21).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals